Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 49.58% vs -35.21% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -13.75% vs 19.29% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Rohto Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 11.79% vs 19.91% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -8.33% vs 42.06% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 49.58% vs -35.21% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.57% vs 13.26% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -13.75% vs 19.29% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1.27% vs 386.15% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






